EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimization of meropenem continuous infusion based on Monte Carlo simulation integrating with degradation study

Nguyen Tran Nam Tien iD, Vu Ngan Binh iD, Pham Thi Thanh Ha, Dang Thi Ngoc Lan, Yong-Soon Cho, Nguyen Phuoc Long iD, Jae-Gook Shin, Nguyen Hoang Anh iD, Truong Anh Quan iD, Do Ngoc Tuan, Nguyen Khac Tiep, Pham The Thach und 2 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0313764 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Nguyen Tran Nam Tien und 13 weiteren Autor:innen. Beteiligte Einrichtung: National Drug Information and Adverse Drug Reactions Monitoring Centre, Hanoi University of Pharmacy, Hanoi, Vietnam. Hauptthemen laut MEDLINE: Meropenem, Monte Carlo Method, Anti-Bacterial Agents, Drug Stability. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hanoi University of Pharmacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Meropenem degradation poses a challenge to continuous infusion (CI) implementation. However, data about the impact of degradation on the probability of target attainment (PTA) of meropenem has been limited. This study evaluated the stability of meropenem brands and the consequence of in-bottle degradation on PTA in different environmental scenarios.

Method

Seven meropenem generic brands prepared at concentrations of 1 g/48mL and 2 g/48mL in saline were examined at 25, 30, and 37°C over 8 h. A linear mixed-effects model was used to estimate degradation rate constant and potential covariates. In-bottle stability data was subsequently integrated as input for a deterministic and stochastic simulation using a published population pharmacokinetic model of critical illness. The impact of the degradation on target attainment at 98% f T>MIC was assessed.

Results

Time, temperature, and infusion concentration were factors affecting the stability of the meropenem solution for all products. The differences in the degradation of seven generics were subtle, so their simulated plasma concentrations were equal. Meropenem CI with 8 h renewal infusion achieved a higher PTA than the extended 3 h infusion, even at the highest degradation condition. The impact of meropenem degradation on PTA was minimal vis-à-vis the meropenem dose, patient’s renal function, and microbial susceptibility. Meropenem degradation reduced PTA by an observable magnitude in patients with augmented renal clearance and difficult-to-treat pathogens. Dose escalation up to 1.5–2g every 8 h could restore this reduction to the target 90% PTA.

Conclusion

Meropenem CI with 8 h of renewal infusion, considering stability even in tropical areas, was feasible to maximize the efficacy to difficult-to-treat pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeropenemMonte Carlo MethodAnti-Bacterial AgentsDrug StabilityHumansInfusions, IntravenousMicrobial Sensitivity TestsTemperatureComputer Simulation

Substanzen

MeropenemAnti-Bacterial Agents

Autor:innen und Institutionen

  • National Drug Information and Adverse Drug Reactions Monitoring Centre, Hanoi University of Pharmacy, Hanoi, Vietnam.
  • Department of Analytical Chemistry and Drug Quality Control, Hanoi University of Pharmacy, Hanoi, Vietnam.
  • Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.
  • Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Republic of Korea.
  • Department of Computing, Goldsmiths, University of London, London, United Kingdom.
  • Department of Pharmaceutical BioTechnology, Hanoi University of Pharmacy, Hanoi, Vietnam.

ORCID-Profile: Nguyen Tran Nam Tien, Vu Ngan Binh, Nguyen Phuoc Long, Nguyen Hoang Anh, Truong Anh Quan, Nguyen Hoang Anh, Vu Dinh Hoa

Förderung

  • Hanoi University of Pharmacy

Zitieren

APA

Tien, N. T. N., Binh, V. N., Ha, P. T. T., Lan, D. T. N., Cho, Y. S., Long, N. P., Shin, J. G., Anh, N. H., Quan, T. A., Tuan, D. N., Tiep, N. K., Thach, P. T., Anh, N. H., & Hoa, V. D. (2024). Optimization of meropenem continuous infusion based on Monte Carlo simulation integrating with degradation study. PLOS ONE. https://doi.org/10.1371/journal.pone.0313764

Vancouver

Tien NTN, Binh VN, Ha PTT, Lan DTN, Cho YS, Long NP, et al. Optimization of meropenem continuous infusion based on Monte Carlo simulation integrating with degradation study. PLOS ONE. 2024. doi:10.1371/journal.pone.0313764

BibTeX
@article{Tien2024,
  author = {Tien, Nguyen Tran Nam and Binh, Vu Ngan and Ha, Pham Thi Thanh and Lan, Dang Thi Ngoc and Cho, Yong-Soon and Long, Nguyen Phuoc and Shin, Jae-Gook and Anh, Nguyen Hoang and Quan, Truong Anh and Tuan, Do Ngoc and Tiep, Nguyen Khac and Thach, Pham The and Anh, Nguyen Hoang and Hoa, Vu Dinh},
  title = {Optimization of meropenem continuous infusion based on Monte Carlo simulation integrating with degradation study},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0313764}
}
Kostenlos starten →